New Drug Trial Hope for MS SufferersApril 16, 2008 - Press Dispensary - The LDN Research Trust (http://www.ldnresearchtrust.org) launches its fundraising effort with MyCharityPage.com (http://www.MyCharityPage.com) to give hope to the two and a half million MS sufferers worldwide. LDN Research Trust expects to raise two million pounds for a drug trial of LDN (Low Dose Naltrexone) as a treatment for Multiple Sclerosis (MS). There are around 85,000 people in the UK suffering from MS and every week around 50 new cases are diagnosed.
- Ends - Notes for editors About LDN Reseach Trust
The LDN Research Trust is a non-profit-making organisation which aims to raise awareness of Low Dose Naltrexone (LDN), alongside promotion and funding of research and clinical trials of LDN as a treatment for Multiple Sclerosis. The charity was set up by a group of MS suffers who experienced improved symptoms as a result of LDN. About My Charity Page My Charity Page Limited is an online fundraising and social networking business aimed at charities and event organisers. The company was founded by Adam Foyster in 2007 and is based in Grantham, Lincolnshire. Adam heads a team of experienced staff covering customer services, accounts, admin, technical development, business development and fundraising. For further information, please contact: |
For more information
My Charity Page LtdAdam Foyster, managing directorTel: 0800 567 7102 / 01476 567283 Email: Site: www.mycharitypage.com Linda Elsegood, LDN Research Trust Tel: 01603 279508 Email:
Click to add
Add this release to ... ![]() ![]() Click to distribute My Charity Page Ltd 's RSS news feed ... |